Report ID: SQSG35G2031
Real World Evidence Analytics Market Size, Share, Growth Analysis, By End user(Pharmaceutical, Biotechnology, Medical Device Companies, Healthcare Payers), By Application(Market Access & Reimbursement, Drug Development & Approval, Post Market Surveillance, Medical Device Development), By Therapeutic Area(Oncology, Cardiovascular, Neurology, Immunology), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35G2031 |
Region:
Global |
Published Date: April, 2024
Pages:
157
|
Tables:
95 |
Figures:
76
Real World Evidence Analytics Market Dynamics
Real World Evidence Analytics Market Driver
- Rising Geriatric Population to Drive Market Growth
Rising geriatric population (and the subsequent increase in the prevalence of chronic diseases) is a key factor driving the growth of the market. The shift from volume- to value-based care, delays in drug development (and the subsequent increase in development costs), growth in R&D spending, and support from regulatory bodies for the use of RWE solutions are some of the other major factors that are driving the growth of this market.
Real World Evidence Analytics Market Restraint
- Lack of Universally Accepted Methodological Standards and Data Processing Infrastructure
A significant obstacle in this industry is the lack of generally acknowledged standards or principles for the design, conduct, analysis, and reporting of RWE. RWE is frequently not regarded as being of high enough quality to be included in the body of evidence used to compare the effectiveness of various treatment choices as a result of this lack of unanimity. This diminishes the information's potential worth and lowers the incentive to produce it. Additionally, this discourages important stakeholders from implementing RWE.
Real World Evidence Analytics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
